S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:PTRA

Proterra (PTRA) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.06
$0.09
50-Day Range
$0.07
$1.89
52-Week Range
$0.06
$7.71
Volume
58.24 million shs
Average Volume
6.69 million shs
Market Capitalization
$15.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.10

Proterra MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
6,019.4% Upside
$4.10 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.87) to ($0.41) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.70 out of 5 stars

Industrials Sector

9th out of 11 stocks

Farm & Heavy Construction Machinery Industry

1st out of 1 stocks


PTRA stock logo

About Proterra (NASDAQ:PTRA) Stock

Proterra Inc. provides commercial vehicles in the United States, the European Union, Canada, the United Kingdom, Australia, Japan, and Türkiye. The company's Proterra Powered & Energy business unit offers battery systems and electrification solutions for commercial vehicle original equipment manufacturer (OEM) customers serving delivery trucks, school buses, coach buses, construction and mining equipment, and other applications; and turnkey fleet-scale, high-power charging solutions and software services, ranging from fleet and energy management software-as-a-service to fleet planning, hardware, infrastructure, installation, utility engagement, and charging optimization. Its Proterra Transit business unit designs, develops, manufactures, and sells electric transit buses as an OEM for North American public transit agencies, airports, universities, and other commercial transit fleets. The company was founded in 2004 and is headquartered in Burlingame, California. On August 07, 2023, Proterra Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.


PTRA Stock News Headlines

Proterra (OTC: PTRA)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Proterra Inc. Common Stock (PTRA)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
PTRA Stock Alert: Proterra Files for Ch. 11 Bankruptcy
See More Headlines
Receive PTRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proterra and its competitors with MarketBeat's FREE daily newsletter.

PTRA Company Calendar

Last Earnings
8/08/2023
Today
9/25/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Farm & Heavy Construction Machinery
Sub-Industry
N/A
Current Symbol
NASDAQ:PTRA
Fax
N/A
Employees
1,010
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.10
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$1.40
Forecasted Upside/Downside
+6,019.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-237,950,000.00
Net Margins
-123.30%
Pretax Margin
-123.30%

Debt

Sales & Book Value

Annual Sales
$309.36 million
Book Value
$1.17 per share

Miscellaneous

Free Float
218,278,000
Market Cap
$15.20 million
Optionable
Not Optionable
Beta
1.08
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Gareth T. JoyceMr. Gareth T. Joyce (Age 50)
    Pres, CEO & Director
    Comp: $862.22k
  • Mr. Julian R. Soell
    Chief Operating Officer
  • Mr. Christopher L. Bailey (Age 42)
    Chief Bus. Officer
    Comp: $603.25k
  • Mr. David S. Black (Age 61)
    Chief Financial Officer
  • Mr. Jeffrey Donald Embt
    Chief Accounting Officer
  • Mr. Dustin Grace (Age 41)
    Chief Technology Officer
  • Mr. Dustin Goodwin
    Chief Information Officer
  • Mr. Aaron Chew
    VP of Investor Relations
  • Jeffrey E. Mitchell
    Interim Gen. Counsel & Corp. Sec.
  • Sara Dadyar
    Chief People Officer













PTRA Stock - Frequently Asked Questions

Should I buy or sell Proterra stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Proterra in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PTRA shares.
View PTRA analyst ratings
or view top-rated stocks.

What is Proterra's stock price forecast for 2023?

2 brokerages have issued 1 year price targets for Proterra's stock. Their PTRA share price forecasts range from $1.40 to $6.00. On average, they anticipate the company's stock price to reach $4.10 in the next year. This suggests a possible upside of 6,019.4% from the stock's current price.
View analysts price targets for PTRA
or view top-rated stocks among Wall Street analysts.

When is Proterra's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our PTRA earnings forecast
.

How were Proterra's earnings last quarter?

Proterra Inc. (NASDAQ:PTRA) posted its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.01. The business had revenue of $85.71 million for the quarter. Proterra had a negative net margin of 123.30% and a negative trailing twelve-month return on equity of 65.70%.

What ETFs hold Proterra's stock?

ETFs with the largest weight of Proterra (NASDAQ:PTRA) stock in their portfolio include SPDR S&P Kensho Intelligent Structures ETF (SIMS).ALPS Clean Energy ETF (ACES).

What is Proterra's stock symbol?

Proterra trades on the NASDAQ under the ticker symbol "PTRA."

Who are Proterra's major shareholders?

Proterra's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (13.22%), BlackRock Inc. (6.58%), State Street Corp (2.47%), Geode Capital Management LLC (1.89%), Northern Trust Corp (0.78%) and Charles Schwab Investment Management Inc. (0.58%). Insiders that own company stock include Christopher L Bailey, Gareth T Joyce, Joann Covington, Julian R Soell and Karina F Padilla.
View institutional ownership trends
.

What is Proterra's stock price today?

One share of PTRA stock can currently be purchased for approximately $0.07.

How much money does Proterra make?

Proterra (NASDAQ:PTRA) has a market capitalization of $15.20 million and generates $309.36 million in revenue each year. The company earns $-237,950,000.00 in net income (profit) each year or ($2.17) on an earnings per share basis.

How many employees does Proterra have?

The company employs 1,010 workers across the globe.

How can I contact Proterra?

Proterra's mailing address is 200 CLARENDON STREET 55TH FLOOR, BOSTON MA, 02116. The official website for the company is www.proterra.com. The company can be reached via phone at 864-438-0000 or via email at ir@proterra.com.

This page (NASDAQ:PTRA) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -